Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of Alzheimer's disease.
Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that longitudinal analysis of the whole bra...
|Main Authors:||, , ,|
No Tags, Be the first to tag this record!